Your browser doesn't support javascript.
Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit.
Mohaghegh, Fatemeh; Hatami, Parvaneh; Aryanian, Zeinab; Fatemi, Farahnaz; Mohseni Afshar, Zeinab.
  • Mohaghegh F; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Hatami P; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Aryanian Z; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Fatemi F; Department of Dermatology, Babol University of Medical Sciences, Babol, Iran.
  • Mohseni Afshar Z; Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Case Rep Med ; 2022: 9880827, 2022.
Article in English | MEDLINE | ID: covidwho-1993147
ABSTRACT
Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Case Rep Med Year: 2022 Document Type: Article Affiliation country: 2022

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Case Rep Med Year: 2022 Document Type: Article Affiliation country: 2022